Related Experiment Video
Updated: May 3, 2026

Cell Membrane Repair Assay Using a Two-photon Laser Microscope
Published on: January 2, 2018
6th Dysferlin Conference, 3-6 April 2013, Arlington, Virginia, USA
Douglas E Albrecht1, Laura E Rufibach1, Bradley A Williams1
1Jain Foundation Inc., 9725 Third Ave NE, Suite 204, Seattle, WA, USA.
Abstract:
The 2013 Dysferlin Conference, sponsored and organized by the Jain Foundation, was held from April 3-6, 2013 in Arlington, VA. Participants included 34 researcher speakers, 5 dysferlinopathy patients and all 8 members of the Jain Foundation team. Dysferlinopathy is a rare disease that typically robs patients of mobility during their second or third decade of life. The goals of these Dysferlin Conferences are to bring experts in the field together so that they will collaborate with one another, to quicken the pace of understanding the biology of the disease and to build effective platforms to ameliorate disease. This is important because the function of dysferlin and how to compensate for its absence is still not well understood, in spite of the fact that the dysferlin gene was identified more than a decade ago. The objective of this conference, therefore, was to share and discuss the newest unpublished research defining the role of dysferlin in skeletal muscle, why its absence causes muscular dystrophy and possible therapies for dysferlin-deficient muscular dystrophy patients.
Related Concept Videos
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Crohn's Disease
Satellite Stem Cells and Muscular Dystrophy
Sex-linked Disorders

